Meditation Produces Psychedelic-Like Brain Changes — Without Any Drugs

A landmark UC San Diego study published in Communications Biology found that seven days of intensive meditation rewired the brain in ways almost identical to psychedelic substances — increasing neuroplasticity, silencing mental chatter, and boosting immune function, all without ingesting anything.

The Study: UC San Diego, April 2025

On April 7, 2025, researchers at the University of California San Diego published a paper in Communications Biology — part of the prestigious Nature portfolio — that sent ripples through both neuroscience and contemplative communities.

Their finding, in plain language: a seven-day intensive meditation retreat produced brain activity patterns that closely resemble those measured in participants who took psilocybin, LSD, or MDMA.

The implications are significant. For decades, psychedelic-assisted therapy has attracted intense scientific interest because of its apparent ability to break rigid mental patterns, reduce the stranglehold of the default mode network (DMN), and produce lasting changes in personality, depression scores, and well-being. The UC San Diego study suggests that dedicated meditation practice can access the same neurological pathways — without any pharmacological substance.

What "Psychedelic-Like Brain Rewiring" Actually Means

To understand the study's significance, it helps to know what psychedelics do to the brain — and why neuroscientists find it so remarkable.

Under psychedelics, two major things happen:

1. The default mode network quiets dramatically. The DMN is the brain's "narrator" — the circuit responsible for self-referential thinking, rumination, the ongoing inner monologue that says "I am this, I want that, I am worried about the other." It is the neurological substrate of ego. Psychedelics suppress DMN activity, which is why people often describe the experience as "ego dissolution" or feeling merged with something larger than themselves.
2. Cross-network connectivity increases. Brain regions that do not normally communicate begin to exchange signals, creating new patterns of neural activity. Neuroscientists call this increased "entropic" brain activity — the brain becomes less predictable, more flexible, more open to new connections. This is what appears to underlie the lasting changes in perspective that many people report after a single psychedelic session.

In the UC San Diego meditation study, researchers measured the same two phenomena in retreat participants:

• Decreased default mode network activity — the inner narrator grew quieter
• Increased cross-network connectivity — the brain became more flexible and integrative
• Elevated endogenous opioid signaling — the brain's natural pleasure and bonding chemicals increased
• Boosted immune signaling markers — a finding with fascinating implications for mind-body medicine

How Meditation Activates the DMN Differently

One of the most interesting nuances in the study is how meditation affects the default mode network versus how psychedelics do it.

Psychedelics suppress the DMN bluntly — they flood the brain with serotonin receptor agonism, effectively silencing the narrator by force. The experience is often intense, uncontrollable, and profound — but also potentially destabilizing, particularly for people with certain mental health vulnerabilities.

Meditation quiets the DMN through a different mechanism: trained attentional control. Through sustained practice, meditators develop the ability to notice when the default mode network fires — when they are lost in thought — and gently redirect attention back to the present moment. Over time, this creates a kind of meta-awareness: the ability to observe mental activity without being absorbed by it.

The result is similar — reduced self-referential chatter, increased presence, greater equanimity — but the pathway is fundamentally different. Meditation trains the neural circuitry; psychedelics pharmacologically override it. Both can lead to the same destination, but via very different roads.

This distinction matters clinically. Meditation's effects are earned through practice, which means they are more stable and transferable to daily life. The meditator does not just have a single transformative experience — they are building a skill that can be applied at will.

The Opioid and Immune Findings

Two secondary findings in the UC San Diego study deserve particular attention.

Increased endogenous opioids: The brain's own opioid system — distinct from pharmaceutical opioids — plays a role in pain modulation, social bonding, and the experience of reward and pleasure. Meditation retreat participants showed measurably elevated endogenous opioid activity. This offers a plausible neurochemical explanation for why many experienced meditators describe their practice as intrinsically rewarding — even blissful — once a certain depth of practice is reached.

Boosted immune signaling: Perhaps the most surprising finding was enhanced immune system signaling in retreat participants. This connects to a growing body of research on the mind-body connection — specifically, the way that chronic psychological stress suppresses immune function, and conversely, that practices that reduce the stress response (like meditation) can measurably improve immune markers. The study adds rigorous data to what contemplative traditions have claimed for millennia: that inner stillness has concrete physiological consequences.

What This Means for Ancient Contemplative Traditions

For thousands of years, contemplative traditions from India, China, Japan, and the Middle East have described meditation as a pathway to states of consciousness that transcend ordinary waking experience. The vocabulary varies — samadhi, satori, fana, unio mystica — but the phenomenological descriptions share remarkable overlap: dissolution of the ordinary sense of self, expansion of awareness, profound peace, and a felt sense of unity with something larger.

Modern neuroscience has often treated these descriptions with skepticism — as poetic exaggeration or motivated self-report. The UC San Diego study, and the broader literature it builds on, represents a significant shift in that stance. When meditators describe silencing the internal narrator and experiencing a kind of ego transparency, their brains show measurable DMN suppression. When they describe feeling flooded with peace or love, their endogenous opioid systems are active.

The ancient and the modern are converging. What monks have described as spiritual transformation, neuroscience is now describing as measurable neuroplasticity. The language is different. The phenomenon appears to be the same.

Practical Implications for Regular Meditators

The UC San Diego study involved a seven-day intensive retreat — a level of practice that most people cannot immediately access. But the research has practical implications for anyone who meditates, or is considering starting.

Depth Matters More Than Duration

The neurological changes observed were associated with the depth and continuity of meditation practice over seven concentrated days, not simply with the total hours accumulated. This suggests that intensive periods — even weekend retreats, or dedicated daily sessions with genuine depth — may produce more significant brain changes than the same number of hours scattered superficially over months.

Consistency Builds the Capacity for Depth

You cannot arrive at a seven-day retreat and immediately access deep states if you have never meditated before. The capacity for meditative depth is built through consistent daily practice over time. Twenty minutes daily for a year creates the neural infrastructure that makes intensive retreat experiences possible and productive.

The Goal Is Subtraction, Not Addition

One of the clearest messages from both the psychedelic and meditation neuroscience literature is that the most transformative changes involve reduction — less DMN activity, less self-referential chatter, less mental noise. Many beginners approach meditation expecting to add something — focus, calm, insight. The deeper practice is about removing the layers of compulsive mental activity that obscure what is already present. As Michelangelo reportedly said of sculpture: the statue is already in the marble; you simply remove what does not belong.

What This Means for Mental Health Treatment

The convergence between meditation and psychedelic neuroscience has significant implications for mental health treatment.

Psilocybin-assisted therapy has shown remarkable efficacy in clinical trials for treatment-resistant depression, PTSD, and addiction. The leading hypothesis for why it works centers on its ability to break rigid patterns of thought and create a temporary period of heightened neuroplasticity during which therapeutic work can produce lasting change.

If meditation can produce similar — though more gradually earned — neuroplasticity, it may offer an accessible, scalable, non-pharmacological complement to emerging psychedelic therapies. For patients who are not candidates for psychedelic treatment, or for whom it is not accessible, meditation might offer a parallel pathway to the same neurological territory.

This is not to say meditation and psychedelics are interchangeable. They are not. Intensive meditation carries its own challenges and contraindications. But the shared neurological mechanisms suggest that they are accessing overlapping systems — and that the boundaries between pharmacological and contemplative approaches to mental health are more permeable than previously thought.

Frequently Asked Questions

Do I need to do a seven-day retreat to get these benefits?

The study focused on a seven-day intensive retreat, which produced the most dramatic results. However, the broader meditation neuroscience literature consistently shows that daily practice — even 10 to 20 minutes — produces measurable changes in DMN activity, stress response, and structural brain changes over months and years. A seven-day retreat accelerates and deepens changes that regular daily practice builds incrementally. Start with consistent daily practice; the retreat becomes available as the capacity deepens.

Is this why experienced meditators describe profound states?

Yes, at least in part. When meditators describe states of profound stillness, expanded awareness, or the dissolution of the ordinary sense of self, the neurological correlates measured in the UC San Diego study offer a plausible mechanistic explanation. The endogenous opioid elevation also explains why deep meditation is often described as intrinsically blissful — the brain is producing its own version of reward and peace.

Could meditation replace psychedelic therapy?

Not directly, and not for everyone. Psychedelic-assisted therapy can produce dramatic shifts in a single session that may take months or years of meditation practice to approach. For people with acute treatment-resistant conditions, the pharmacological acceleration may be both necessary and appropriate. That said, meditation offers something psychedelics cannot: a trainable skill that can be accessed voluntarily, in any circumstances, that becomes more reliable and accessible over time. The two approaches are likely most powerful in combination.

What type of meditation produces these effects?

The UC San Diego study used a form of focused attention and open monitoring meditation typical of intensive retreat settings in the Theravada Buddhist tradition. However, the broader research suggests that multiple forms of meditation — mindfulness, loving-kindness, transcendental meditation, Zen — produce overlapping neurological changes when practiced with sufficient depth and consistency. The common thread appears to be sustained, deliberate attention training, rather than any specific technique.

Are there risks to intensive meditation?

Yes. Research by Willoughby Britton at Brown University has documented a range of challenging experiences associated with intensive meditation, including anxiety, depersonalization, and in rare cases, psychosis-like states — particularly in people with certain mental health vulnerabilities. Intensive retreat settings are not universally suitable. Anyone with a history of psychosis, dissociative disorder, or severe PTSD should practice under qualified guidance and proceed with appropriate caution. Daily practice at moderate intensity is safe for the vast majority of people.